KS Tan, LC McFarlane and BJ Lipworth
Department of Clinical Pharmacology, University of Dundee, Ninewells Hospital and Medical School, Scotland, United Kingdom.

Female sex-steroid hormones may play an important influence in asthma. The aim of this study was to compare airway reactivity to adenosine monophosphate (AMP) in female asthmatics with natural menstrual cycles and those taking the oral combined contraceptive pill (OCP). Eighteen asthmatic subjects were evaluated. Nine subjects, mean (SEM) age, 24 (6) years, FEV1 93% (10) predicted, with natural cycles (group 1) were compared with nine subjects, age 24 (6) years, FEV1 93% (9) predicted taking the OCP (group 2). Group 1 subjects were evaluated at the follicular (visit 1) and luteal (visit 2) phases; group 2 subjects were evaluated during the week off OCP (visit 1) and at the end of the OCP cycle (visit 2). At each visit, serum progesterone and estradiol were measured. Airway reactivity to AMP was evaluated and expressed as PC20 (FEV1; mg/ml). Morning and evening peak expiratory flow rates (PEFR) were monitored throughout the study. In group 1, there was a significant increase in serum progesterone (nmol/l) and estradiol (pmol/l). (Visit 1 vs. 2): 2.5 vs. 13.5 (95% CI 2.1 to 19.9; p = 0.02) and 152.3 vs. 358.1 (95% CI 113.0 to 298.5; p < 0.001), respectively. In group 2, however, there was no increase between visit 1 vs. 2 in hormones: 0.9 vs. 1.0 and 75.7 vs. 21.8 for progesterone and estradiol, respectively. There was a significant increase in airway reactivity in group 1 during the luteal phase. Geometric mean PC20 (mg/ml) was 18.8 and 4.7 at visit 1 and 2, respectively: a 4.0-fold difference (95% CI 1.25 to 13.03; p = 0.03) amounting to two doubling doses. In contrast, there was no change in PC20 in group 2. Geometric mean PC20 was 23.5 and 21.4: a 1.06-fold difference (95% CI 0.41 to 2.78; p = 0.83). In group 1, morning and evening PEFR (l/min) were significantly different at both visits: at visit 1 (A.M. PEFR vs. P.M. PEFR) 403 vs. 430 (95% CI 5 to 50; p < 0.001) and visit 2, 415 vs. 439 (95% CI 1 to 46; p < 0.001). In group 2, there was no significant difference in diurnal PEFR variability at both visits; 411 vs. 417 at visit 1 and 413 vs. 427 at visit 2. In conclusion, asthmatic patients receiving the OCP had attenuated cyclical change in airway reactivity as well as reduced diurnal PEFR variability, which was associated with suppression of the normal luteal phase rise in sex-hormones.

This article has been cited by other articles:

				P. J. Mandhane, S. E. Hanna, M. D. Inman, J. M. Duncan, J. M. Greene, H.-Y. Wang, and M. R. Sears Changes in Exhaled Nitric Oxide Related to Estrogen and Progesterone During the Menstrual Cycle Chest, November 1, 2009; 136(5): 1301 - 1307. [Abstract] [Full Text] [PDF]

				B E Brenner, T M Holmes, B Mazal, and C A Camargo Jr Relation between phase of the menstrual cycle and asthma presentations in the emergency department Thorax, October 1, 2005; 60(10): 806 - 809. [Abstract] [Full Text] [PDF]

				R. G. Barr, C. C. Wentowski, F. Grodstein, S. C. Somers, M. J. Stampfer, J. Schwartz, F. E. Speizer, and C. A. Camargo Jr Prospective Study of Postmenopausal Hormone Use and Newly Diagnosed Asthma and Chronic Obstructive Pulmonary Disease Arch Intern Med, February 23, 2004; 164(4): 379 - 386. [Abstract] [Full Text] [PDF]

				M Osman Therapeutic implications of sex differences in asthma and atopy Arch. Dis. Child., July 1, 2003; 88(7): 587 - 590. [Abstract] [Full Text] [PDF]

				C. Janson, S. Chinn, D. Jarvis, and P. Burney Determinants of cough in young adults participating in the European Community Respiratory Health Survey Eur. Respir. J., October 1, 2001; 18(4): 647 - 654. [Abstract] [Full Text] [PDF]

				I. Aziz, A. M. Wilson, and B. J. Lipworth Effects of Once-Daily Formoterol and Budesonide Given Alone or in Combination on Surrogate Inflammatory Markers in Asthmatic Adults Chest, October 1, 2000; 118(4): 1049 - 1058. [Abstract] [Full Text] [PDF]

				S. J. FOWLER, O. J. DEMPSEY, E. J. SIMS, and B. J. LIPWORTH Screening for Bronchial Hyperresponsiveness Using Methacholine and Adenosine Monophosphate . Relationship to Asthma Severity and beta 2-Receptor Genotype Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1318 - 1322. [Abstract] [Full Text] [PDF]

				J. L. ZIMMERMAN, P. G. WOODRUFF, S. CLARK, and C. A. CAMARGO Jr. Relation between Phase of Menstrual Cycle and Emergency Department Visits for Acute Asthma Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 512 - 515. [Abstract] [Full Text] [PDF]

				M. R Becklake and F. Kauffmann Gender differences in airway behaviour over the human life span Thorax, December 1, 1999; 54(12): 1119 - 1138. [Full Text]

				I. Aziz and B. J. Lipworth A Bolus of Inhaled Budesonide Rapidly Reverses Airway Subsensitivity and {beta}2-Adrenoceptor Down-regulation After Regular Inhaled Formoterol Chest, March 1, 1999; 115(3): 623 - 628. [Abstract] [Full Text] [PDF]

				L. Forbes Do exogenous oestrogens and progesterone influence asthma? Thorax, March 1, 1999; 54(3): 265 - 267. [Full Text]

				B. LEYNAERT, J. BOUSQUET, C. HENRY, R. LIARD, and F. NEUKIRCH Is Bronchial Hyperresponsiveness More Frequent in Women than in Men? . A Population-based Study Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1413 - 1420. [Abstract] [Full Text]